ema glp-1 vision loss recommendation ophthalmology november 2025 Last month, the European Medicines Agency recommended that product information for #semaglutide medicines— the active ingredient in #Ozempic, #Rybelsus, and #Wegovy — be updated to include non-arteritic anterior ischemic optic neuropathy or # Ozempic Lawsuits | Wegovy Lawsuits

A 2018 Sports Medicine review (Fielding et al.) suggested L-Carnitine supplementation may moderately reduce muscle damage, fatigue, and enhance exercise capacity and post-exercise recovery

John's wort, garcinia cambogia, and other weight-loss supplements should be discussed with healthcare providers NSAIDs : May increase gastrointestinal irritation risk Important FDA guidance : Zepbound should not be used with other GLP-1 receptor agonists or other tirzepatide products

PlexusDx Precision Peptide Genetic Test evaluates key variants in these pathways to provide context for your treatment plan

The FDA-approved label for Kybella notes that injections should be administered only by a health care professional

[132:29] Andrew Huberman Thanks

Altmed discusses benefits, risks, contraindications, expected follow-up, and realistic goals rather than treating injections as a quick fix